Search Results 391-400 of 90896 for Metastasis

  1. Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001) - Mayo Clinic

    Clinical Trials · Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung ...

  2. SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab - Mayo Clinic

    The primary objective of this study is to determine the safety profile of SX-682 alone and in combination with pembrolizumab in subjects with metastatic ...

  3. YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma - Mayo Clinic

    ... metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety and tolerability and determine RP2D of YH001 ...

  4. INCB161734 for Advanced or Metastatic Solid Tumors With KRAS G12D Mutation - Mayo Clinic

    The purpose of this study is to determine the safety and tolerability of INCB161734 as a single agent or in combination with other anticancer therapies.

  5. Clinical trials - Oncology (Medical)

    ... metastasis and/or positive peritoneal cytology undergoing robotic cytoreduction and hyperthermic intraperitoneal chemotherapy. Human Saliva as a Non ...

  6. Overview - Department of Cancer Biology - Mayo Clinic Research

    ... metastasis. Research is particularly strong in tumor invasion and metastasis, a key event during tumor progression that accounts for more than 90% of cancer ...

  7. Ultrasound-guided percutaneous ethanol ablation of neck nodal metastases in patients with papillary thyroid carcinoma - Mayo Clinic

    Most patients with papillary thyroid cancer (PTC) present with disease confined to the thyroid; however, neck nodal metastases (NNM) may be found in up to ...

  8. Head And Neck Cancers Clinical Trials - Mayo Clinic Research

    ... metastatic carcinoma of the head and neck who have progressed during or after treatment with a platinum containing regimen for recurrent/metastatic disease.

  9. FDA approves earlier use of lutetium Lu 177 vipivotide tetraxetan for patients with PSMA-positive metastatic castration-resistant prostate cancer - Mayo Clinic

    The FDA recently expanded the indication of lutetium Lu 177 vipivotide tetraxetan for PSMA-positive metastatic castration-resistant prostate cancer, ...

  10. A Study to Compare Single Fraction Stereotactic Radiosurgery Compared with Fractionated Stereotactic Radiosurgery in Treating Patients With Resected Metastatic Brain Disease - Mayo Clinic

    Note: The metastases size restriction does not apply to the resected brain metastasis. One brain metastasis must be completely (gross total resection) ...